Mefloquine targets NLRP3 to reduce lipopolysaccharide‐induced systemic inflammation and neural injury
Siyuan Jiang, Tian Tian, Wenjie Li, Ting Liu, Cong Wang, Gang Hu, Ren‐Hong Du, Yang Liu, Ming Lu
Topics & Concepts
MefloquineInflammasomePyrin domainPharmacologyInflammationMedicineDrugLipopolysaccharideChloroquineImmunologyMalariaInflammasome and immune disordersSphingolipid Metabolism and SignalingCholesterol and Lipid Metabolism